The Therapeutic Use category is associated with which of the following?

• A. Development Methodology covers issues and considerations related to the development plan and its component studies
• B. Early pharmacokinetic sampling in humans
• C. Post-marketing surveillance
• D. Labeling updates and advertising requirements

Answer: (A)

The Therapeutic Use category focuses on how a drug’s intended use is developed and demonstrated. It guides the overall development methodology—the plan for clinical development to support a specific therapeutic use, including choosing indications, designing trials, selecting endpoints, defining populations, and sequencing studies to build robust evidence of safety and efficacy. This makes it the best fit for describing development planning and its component studies. It isn’t about early pharmacokinetic sampling in humans, which belongs to pharmacokinetics; nor is it about post-marketing surveillance, which involves safety monitoring after approval; nor about labeling updates and advertising requirements, which concern regulatory labeling and marketing communications.